LYONDELLBASELL INDU-CL A (LYB)

NL0009434992 - Common Stock

99.74  +0.62 (+0.63%)

After market: 99.74 0 (0%)

Fundamental Rating

5

Taking everything into account, LYB scores 5 out of 10 in our fundamental rating. LYB was compared to 84 industry peers in the Chemicals industry. LYB has an average financial health and profitability rating. LYB has a valuation in line with the averages, but it does not seem to be growing.



6

1. Profitability

1.1 Basic Checks

In the past year LYB was profitable.
In the past year LYB had a positive cash flow from operations.
LYB had positive earnings in each of the past 5 years.
LYB had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a decent Return On Assets value of 5.76%, LYB is doing good in the industry, outperforming 75.00% of the companies in the same industry.
LYB's Return On Equity of 16.24% is fine compared to the rest of the industry. LYB outperforms 76.19% of its industry peers.
With a decent Return On Invested Capital value of 8.76%, LYB is doing good in the industry, outperforming 78.57% of the companies in the same industry.
LYB had an Average Return On Invested Capital over the past 3 years of 14.60%. This is significantly above the industry average of 7.44%.
The 3 year average ROIC (14.60%) for LYB is well above the current ROIC(8.76%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.76%
ROE 16.24%
ROIC 8.76%
ROA(3y)10.55%
ROA(5y)9.36%
ROE(3y)31.46%
ROE(5y)30.87%
ROIC(3y)14.6%
ROIC(5y)12.53%

1.3 Margins

Looking at the Profit Margin, with a value of 5.17%, LYB is in the better half of the industry, outperforming 60.71% of the companies in the same industry.
In the last couple of years the Profit Margin of LYB has declined.
LYB has a Operating Margin (8.12%) which is in line with its industry peers.
In the last couple of years the Operating Margin of LYB has declined.
With a Gross Margin value of 12.35%, LYB is not doing good in the industry: 79.76% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of LYB has declined.
Industry RankSector Rank
OM 8.12%
PM (TTM) 5.17%
GM 12.35%
OM growth 3Y4.04%
OM growth 5Y-8.32%
PM growth 3Y0.06%
PM growth 5Y-15.65%
GM growth 3Y1.51%
GM growth 5Y-5.08%

6

2. Health

2.1 Basic Checks

LYB has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
LYB has less shares outstanding than it did 1 year ago.
The number of shares outstanding for LYB has been reduced compared to 5 years ago.
Compared to 1 year ago, LYB has an improved debt to assets ratio.

2.2 Solvency

LYB has an Altman-Z score of 2.83. This is not the best score and indicates that LYB is in the grey zone with still only limited risk for bankruptcy at the moment.
LYB has a Altman-Z score of 2.83. This is in the better half of the industry: LYB outperforms 76.19% of its industry peers.
The Debt to FCF ratio of LYB is 4.17, which is a neutral value as it means it would take LYB, 4.17 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.17, LYB is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
LYB has a Debt/Equity ratio of 0.86. This is a neutral value indicating LYB is somewhat dependend on debt financing.
LYB has a Debt to Equity ratio (0.86) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 4.17
Altman-Z 2.83
ROIC/WACC1.19
WACC7.34%

2.3 Liquidity

A Current Ratio of 2.12 indicates that LYB has no problem at all paying its short term obligations.
LYB's Current ratio of 2.12 is in line compared to the rest of the industry. LYB outperforms 47.62% of its industry peers.
LYB has a Quick Ratio of 1.32. This is a normal value and indicates that LYB is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of LYB (1.32) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.32

2

3. Growth

3.1 Past

The earnings per share for LYB have decreased strongly by -28.58% in the last year.
Measured over the past years, LYB shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.78% on average per year.
Looking at the last year, LYB shows a very negative growth in Revenue. The Revenue has decreased by -14.21% in the last year.
The Revenue has been growing slightly by 1.06% on average over the past years.
EPS 1Y (TTM)-28.58%
EPS 3Y15.71%
EPS 5Y-4.78%
EPS growth Q2Q-39.04%
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y13.99%
Revenue growth 5Y1.06%
Revenue growth Q2Q-3.14%

3.2 Future

LYB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.56% yearly.
The Revenue is expected to decrease by -0.34% on average over the next years.
EPS Next Y-4.54%
EPS Next 2Y6.43%
EPS Next 3Y6.45%
EPS Next 5Y4.56%
Revenue Next Year-0.78%
Revenue Next 2Y-7.51%
Revenue Next 3Y-5.06%
Revenue Next 5Y-0.34%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.75, the valuation of LYB can be described as correct.
79.76% of the companies in the same industry are more expensive than LYB, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of LYB to the average of the S&P500 Index (28.02), we can say LYB is valued rather cheaply.
LYB is valuated reasonably with a Price/Forward Earnings ratio of 10.01.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LYB indicates a rather cheap valuation: LYB is cheaper than 88.10% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.58, LYB is valued rather cheaply.
Industry RankSector Rank
PE 12.75
Fwd PE 10.01

4.2 Price Multiples

77.38% of the companies in the same industry are more expensive than LYB, based on the Enterprise Value to EBITDA ratio.
LYB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LYB is cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.1
EV/EBITDA 8.56

4.3 Compensation for Growth

The decent profitability rating of LYB may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.43%
EPS Next 3Y6.45%

6

5. Dividend

5.1 Amount

LYB has a Yearly Dividend Yield of 5.06%, which is a nice return.
Compared to an average industry Dividend Yield of 3.14, LYB pays a better dividend. On top of this LYB pays more dividend than 90.48% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, LYB pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.06%

5.2 History

The dividend of LYB has a limited annual growth rate of 4.19%.
LYB has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)4.19%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

LYB pays out 77.28% of its income as dividend. This is not a sustainable payout ratio.
The dividend of LYB is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP77.28%
EPS Next 2Y6.43%
EPS Next 3Y6.45%

LYONDELLBASELL INDU-CL A

NYSE:LYB (5/6/2024, 7:13:07 PM)

After market: 99.74 0 (0%)

99.74

+0.62 (+0.63%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap32.48B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 5.06%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 12.75
Fwd PE 10.01
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.76%
ROE 16.24%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.12%
PM (TTM) 5.17%
GM 12.35%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.12
Quick Ratio 1.32
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-28.58%
EPS 3Y15.71%
EPS 5Y
EPS growth Q2Q
EPS Next Y-4.54%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y13.99%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y